HUMAIN and Infra Announce AI and Digital Financing Framework Agreement

 Davos, Switzerland -

HUMAIN and the National Infrastructure Fund (“Infra”) announced on the sidelines of the World Economic Forum (WEF) Annual Meeting 2026 in Davos, Switzerland, a Strategic Financing Framework Agreement of up to $1.2 billion to support the expansion of AI and digital infrastructure projects in the Kingdom of Saudi Arabia.

The Framework Agreement outlines non-binding financing terms for HUMAIN’s development of up to 250 MW of hyperscale AI data center capacity. These data centers will deploy leading edge GPUs for AI training and inference and support HUMAIN’s local, regional and global customers.

In addition, Infra and HUMAIN have agreed to explore the establishment of an AI data center investment platform. This would be anchored by the two organizations and structured to facilitate participation by global and local institutional investors to support further scaling of HUMAIN’s AI strategy.

Today’s Framework Agreement underscores Infra’s key role in partnering with its counterparts to accelerate the delivery of infrastructure assets that are foundational to economic transformation and long-term productivity. It also demonstrates HUMAIN’s commitment to deploying scalable computing capacity to capture growing commercial demand for advanced AI and data processing services.

“Demand growth for advanced compute is intensifying, and this Framework Agreement positions HUMAIN to respond with speed and scale, In partnership with Infra, our goal is to deliver world-class AI data center infrastructure that enterprises can rely on as their compute needs grow more complex.”

TAREQ AMIN, CHIEF EXECUTIVE OFFICER OF HUMAIN.

“Today’s Framework Agreement is an important step in expanding Infra’s role of unlocking infrastructure investment opportunities in the Kingdom. Our partnership with HUMAIN will activate new pathways to grow institutional investment and develop the digital economy through enabling AI infrastructure.”

ENG. ESMAIL ALSALLOM, CHIEF EXECUTIVE OFFICER OF INFRA

About Infra

The National Infrastructure Fund (Infra) is the Kingdom’s lead development financing partner for infrastructure. Infra catalyzes higher levels of private sector investment to accelerate the delivery of infrastructure projects critical to the Kingdom’s social and economic transformation. Infra provides a flexible financing offering, supporting infrastructure projects across all sectors, focusing on achieving the goals of Vision 2030 and supporting the objectives of the Saudi Green Initiative. The National Infrastructure Fund is a supervised entity of the National Development Fund.

About HUMAIN

HUMAIN, a PIF company, is a global artificial intelligence company delivering full-stack AI capabilities across four core areas: next-generation data centers; hyper-performance infrastructure and cloud platforms; advanced AI models, including some of the world’s most advanced Arabic large language models developed in the Arab world; and transformative AI solutions that combine deep sector insight with real-world execution.

HUMAIN’s end-to-end model serves both public and private sector organizations, unlocking value across industries, driving digital transformation, and strengthening capabilities through human–AI collaboration. With a growing portfolio of sector-specific AI products and a core mission focused on intellectual property development and global talent leadership, HUMAIN is engineered for international competitiveness and technological excellence.

Permalink

https://www.aetoswire.com/en/news/SAD2312026E

Contacts

Danah Alhumaid

dalhumaid@mep.gov.sa

SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing

 (BUSINESS WIRE) -- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to continue its listing on the Nasdaq Stock Market, subject to stated conditions focused on timely completion of its financial audit and remediation of filing delinquencies.

Under the Panel’s decision, SINOVAC must, on or before May 11, 2026, demonstrate compliance with Nasdaq Listing Rule 5250(c)(1) and Listing Rule 5250(c)(2) by completing filings of its annual report for the year ended December 31, 2024 on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of year 2025 on Form 6-K.

As disclosed on January 4, 2026, the Company has engaged Zhonghua Certified Public Accountants LLP (“Zhonghua”) as its independent registered public accounting firm. SINOVAC is working diligently with Zhonghua to complete the required audit and to regain compliance with its filing obligations by May 11, 2026.

The Company remains committed to completing the requisite audit procedures and regulatory filings as expeditiously as practicable and to maintaining compliance with applicable U.S. Securities and Exchange Commission and Nasdaq requirements.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of "supply vaccines to eliminate human diseases", the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.

The company's diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive®, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.

SINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world's first inactivated SARS vaccine (Phase I completed), China's first H5N1 influenza vaccine (Panflu®), the world's first H1N1 influenza vaccine (Panflu.1®), and CoronaVac®, the most widely used inactivated COVID-19 vaccine globally.

Beyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.

With a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.

For more information, please see the Company’s website at www.sinovac.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260122376718/en/

Permalink

https://www.aetoswire.com/en/news/2201202652564

Contacts

Investor and Media Contact

Sinovac Biotech Ltd.

Email: ir@sinovac.com

illumynt Appoints Chris Tejeda as Chief Revenue Officer

 BOSTON - Wednesday, 21. January 2026

(BUSINESS WIRE) -- illumynt today announced the promotion of Chris Tejeda to Chief Revenue Officer (CRO), reflecting the company’s continued growth and expanding global footprint.

In his new role, Tejeda will lead illumynt’s global revenue strategy, customer engagement, and strategic partnerships as demand accelerates for secure, technology-driven IT Asset Disposition (ITAD) solutions.

“Chris has been instrumental in aligning our commercial strategy with the evolving needs of hyperscale and enterprise customers,” said CEO Joerg Herbarth. “As AI accelerates infrastructure refresh cycles and raises the bar for security and compliance, his leadership will be critical to scaling illumynt with focus, transparency, and customer trust.”

Tejeda brings extensive experience in enterprise technology services and has played a key role in illumynt’s recent momentum, including significant revenue growth and the expansion of advanced capabilities across AI/GPU diagnostics, automation, and value recovery.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260121903784/en/

Permalink

https://www.aetoswire.com/en/news/2101202652490

Contacts

Alyson Kaye

617.407.6381

Sisvel Launches Wi-Fi Multimode Patent Pool

 LUXEMBOURG - Thursday, 22. January 2026 AETOSWire 

Ten patent owners establish licensing solution covering Wi-Fi 6 and Wi-Fi 7 standards

(BUSINESS WIRE) -- Sisvel has launched a groundbreaking Wi-Fi Multimode patent pool offering access to standard essential patents owned by 10 Wi-Fi 6 and Wi-Fi 7 technology leaders.

As the successor to Sisvel’s highly successful Wi-Fi 6 patent pool – which, over a three-year period, closed agreements with nearly 40 companies, including Acer, Netgear, Cisco and HP – the new programme offers an efficient way to access essential Wi-Fi rights for years to come.

The 10 founding patent owners in the Wi-Fi Multimode programme are Huawei, KPN, Mitsubishi Electric, Orange, Panasonic, Philips, Aegis 11 SA (a Sisvel affiliate), SK Telecom, Wilus and ZTE.

In addition, Sony Group Corporation has taken a licence under the Wi-Fi Multimode programme. This early agreement with a sophisticated and globally recognised Wi-Fi leader and implementer underlines the pool’s strong value proposition and the efforts made by Sisvel to engage with all parts of the market during pool formation.

Giorgia Varvelli has been named Wi-Fi Multimode programme manager; she previously held the same role for the Wi-Fi 6 patent pool, playing an instrumental role in its success.

“Today’s announcement is a milestone for Wi-Fi licensing,” says Sisvel President and CEO Mattia Fogliacco. “We have made it simple and straightforward to access essential rights across multiple Wi-Fi generations in a single transaction. This is the product of years of hard work by the Sisvel team and all our partners. We look forward to repaying the market’s trust in us to manage this critically important licensing programme.”

“It is exciting to be working with our returning Wi-Fi 6 licensors and the new patent owners that have come on board,” adds Varvelli. “With this programme, we continue to send a strong signal to the market: Wi-Fi innovation has value; and there is a transparent, efficient way to license essential rights. This will drive more R&D, more invention and more advanced technologies. Together with leading Wi-Fi implementers Sony, we are building a Wi-Fi licensing environment that powers innovation.”

Visit https://www.wifipatentpool.com for more information.

About Sisvel

Sisvel is driven by a belief in the importance of collaboration, ingenuity and efficiency to bridge the needs of patent owners and those who wish to access their technologies. In a complex and constantly evolving marketplace, our guiding principle is to create a level playing field with the development and implementation of flexible, accessible, commercialisation solutions.

Sisvel | We Power Innovation

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260122892826/en/

Permalink

https://www.aetoswire.com/en/news/2201202652562

Contacts

Media Contact

Giulia Dini

Head of Communications

Tel: +34 93 131 5570

giulia.dini@sisvel.com

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

ZUG, Switzerland - Thursday, 22. January 2026


    At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and contouring following its European Union (EU) Medical Device Regulation (MDR) certification, expanding its use to four body areas1-7
    Multiple studies will reinforce the safety and efficacy of Galderma’s hyaluronic acid (HA) treatments range, including post-marketing data on Restylane® Shaype™ in shaping the chin, Restylane Lyft™ in improving jawline definition, Restylane Skinboosters™ in smoothing fine lines and wrinkles in the décolletage and Restylane Volyme™ in correcting hollowing of the temples8-11
    New data on the innovative neuromodulator Relfydess™ (RelabotulinumtoxinA) will reinforce its rapid onset as early as Day 1 and sustained efficacy through six months for frown lines and crow’s feet12
    As a leader in injectable aesthetic innovation, Galderma will showcase its superior science and educational capabilities at the congress

 

(BUSINESS WIRE) -- Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026. The company will also showcase its leadership in community education through a number of events including two symposia, a live anatomy workshop, multiple masterclasses and meet-the-expert sessions, and a booth that will delve into the science behind its innovations.

“With ten posters spanning all key aesthetic treatment modalities and areas across the face and body, our data at IMCAS truly showcases the breadth and versatility of our injectable aesthetics portfolio and how we continue to drive innovation with our trusted products. In tandem with our first-class Galderma Aesthetic Injector Network (GAIN) educational activities, conducted in partnership with renowned experts, we are equipping practitioners with all the tools they need to take a personalized and holistic approach to treatment.”

BILL ANDRIOPOULOS, PH.D.

HEAD OF GLOBAL MEDICAL AFFAIRS

GALDERMA
    

 

Biostimulation: Sculptra’s innovative approach to regenerative aesthetics for the face and body backed by experts
In response to patients increasingly seeking harmony between facial and body aesthetics, Galderma recently announced the EU MDR certification of Sculptra, the first proven regenerative biostimulator, expanding its current clinical use to the body.3 At IMCAS, guidance developed by 13 international experts on Sculptra’s four MDR-approved indications – the gluteal area, posterior thighs, décolletage, and upper arms – will be presented.1 The experts concluded that Sculptra’s benefits can be complemented with Restylane Skinboosters in the décolletage for comprehensive body rejuvenation, and recommended injection volumes for Sculptra to be used in the posterior thighs, upper arms and gluteal area to improve aesthetic appearance, including skin firmness and reduced appearance of cellulite.1

Results from an expert review of data on Sculptra will also be presented, providing additional evidence of its regenerative properties.2 This includes fibroblast activation leading to stimulation of collagen, elastin and other proteins involved in extracellular matrix regeneration and adipogenesis (the formation of healthy fat cells).2 This clinically presents as long-term improvements such as increased volume, elasticity, and skin thickness.2

A final poster will examine the ease of Sculptra’s reconstitution process compared with two other poly-L-lactic acid biostimulators, finding that healthcare professionals had a strong preference for Sculptra’s reconstitution process and positively rated its speed of administration from preparation to injection.13

HA treatments: The Restylane range demonstrates its versatility in meeting diverse patient needs
Data from across Galderma’s portfolio of Restylane HA treatments will be presented supporting its versatile use on the face and décolletage, with a range of gel formulations to meet personalized needs from providing structural support to smoothing lines and wrinkles:

    The ARTIST post-marketing study found that Restylane Shaype, powered by new NASHA HD™ technology, is a safe and effective treatment for shaping the chin with natural-looking results, alone or in combination with Restylane Defyne™ and Restylane Lyft to provide lift, shape, and definition for diverse aesthetic needs.8 The poster also supports that Restylane Shaype has the highest G-prime (a measure of firmness) compared with other HA treatments produced with different manufacturing technologies, allowing for greater correction with lower injection volumes.8

    A study of Restylane Lyft for jawline definition showed it was effective and safe, and resulted in high subject satisfaction and aesthetic improvement through 12 months.9

    A study evaluating the effectiveness and safety of Restylane Skinboosters for correction of moderate-to-severe wrinkles in the décolletage found that it was well tolerated and highly efficacious with a significant improvement through Week 32 and high patient satisfaction.10

    A study of Restylane Volyme showed that it was safe and effective for correction of temple hollowing, with high and sustained results through Month 18 and high patient satisfaction.11

Neuromodulation: Supporting Relfydess’ next-generation performance
Results will be presented from an analysis of wrinkle morphology and dynamic skin strain in the RELAX and EXPRESSION trials investigating Relfydess – the first and only ready-to-use liquid neuromodulator created with PEARLTM Technology.12,14 Results reinforce its onset of action as early as Day 1 in patients with moderate-to-severe frown lines and crow’s feet, with sustained improvements for six months.12 Expert-led consensus recommendations will also be shared addressing important unmet needs in real-world clinical practice and providing clear guidance for the practical use of Relfydess, helping healthcare professionals select the optimal treatment protocol for their patients.15

Spearheading community education and awareness around unmet patient needs
Galderma will also present findings from a global survey of over 4,300 women across five continents linking menopause to several skin changes, including wrinkles, loss of firmness, dryness and dull skin, and the potential role of aesthetic treatments to address them.16,17 As part of its response to this, Galderma will host a symposium titled ‘Menopause in the Mirror: Challenges, Science and Aesthetic Solutions’ on Friday, January 30 at 10:30 AM – 12:30 PM CET in Grand Amphi - Level 1.

A second symposium, titled ‘Exploring Breakthroughs in Injectable Regeneration for the Face, Body, and Skin Health’ will delve into the growing demand for holistic regenerative aesthetic solutions and take place on Thursday January 29 at 1:30 – 2:30 PM CET in Room 251, Level 2.

More information about Galderma’s activities at IMCAS 2026 can be found here.

About Sculptra
Sculptra is the first proven regenerative biostimulator, with a unique poly-L-lactic acid (PLLA-SCA™) formulation, to provide progressive and sustained regenerative effect across all three skin layers.3,18-24 Sculptra reverses aging processes in the skin, including degradation of the extracellular matrix, which results in volume loss, laxity, and the appearance of wrinkles.3,18,19,25-27 Sculptra progressively rebuilds the skin’s structural foundation by encouraging the remodeling of components of the extracellular matrix, such as elastin and collagen, helping to gradually restore volume, firmness, radiance and skin quality, and the look of fullness to wrinkles and folds over time.3-7,18,19,28 Sculptra has been shown to provide visible improvements as early as one month after treatment, with results lasting up to two years.3,6,23,28,29

About the Restylane portfolio
Restylane HA treatments are designed differently to go beyond volumizing for natural-looking results.30-33 Our HA is minimally modified and our innovative manufacturing process preserves its biocompatibility while creating individual products designed for a specific purpose.34-37 Powered by NASHA®, NASHA HD, OBT™ and SB-NASHA™ technologies, Restylane offers gels with the highest firmness to the highest flexibility, enabling personalized treatments that deliver structural support, natural-looking results, and a healthy glow.38-41 Trusted for almost three decades, our HA gels work in sync with your skin for 100% natural-looking results.30,42,43

About Relfydess (RelabotulinumtoxinA)
Pioneered by Galderma, Relfydess is the first and only ready-to-use liquid neuromodulator created with PEARL Technology that is designed to preserve molecule integrity.14 PEARL Technology is designed to deliver a highly active, innovative, complex-free molecule, with up to 39% of patients seeing effects from day one and up to 75% of patients maintaining improvements for six months.14,44,45 Relfydess is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.46,47 It was entirely created and manufactured by Galderma to expand its neuromodulator portfolio as part of the broadest Injectable Aesthetics portfolio on the market. Relfydess received a marketing authorization in several markets. RelabotulinumtoxinA is an investigational drug product in the U.S. Authorization conditions may vary internationally.

About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

    Haddad A, et al. International consensus: Sculptra®/Restylane® Skinboosters™ for non-facial rejuvenation. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Fabi SG, et al. Regenerative aesthetic effects of poly L-lactic acid treatment. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Sculptra®. EU Instructions for Use. 2025. Available online. Accessed January 2026.

    Galderma. Data on File. MA-57540.

    Nikolis A, et al. A Prospective, Multicenter Trial on the Efficacy and Safety of Poly-L-Lactic Acid for the Treatment of Contour Deformities of the Buttock Regions. J Drugs Dermatol. 2022;21(3):295–303. doi: 10.36849/JDD.5924.

    Beleznay K, et al. Safety and Effectiveness of Poly-L-lactic acid (PLLA-SCA) for the Improvement in Appearance of Cellulite – A Pilot Study. Poster presented at the IMCAS World Congress; February 1-3, 2024; Paris, France.

    Mazzuco R, et al. Clinical and Histological comparative outcomes after injections of Poly-L-Lactic Acid and Calcium Hydroxyapatite in arms – a split side study. J Cosmet Dermatol. 2022;21(12):6727–6733. doi: 10.1111/jocd.15356. Epub 2022 Sep 20.

    Nikolis A, et al. A new NASHA-HD, high G’ hyaluronic acid (HA) injectable evaluated for chin treatment in combination with lower face and mid-face HA filler treatment. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Rivers J, et al. Effectiveness and safety of Restylane® Lyft™ Lidocaine for jaw-line definition: A 12-month randomized controlled study. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Moradi A, et al. Effectiveness and safety of a hyaluronic acid skin quality injectable for the correction of wrinkles in the décolletage area. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Nestor M. Safety and effectiveness of an OBT™ hyaluronic acid filler for temple hollowing treatment: a randomized, controlled, clinical investigation. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Moradi A, et al. Objective image analysis of wrinkle morphology and dynamic skin strain in GLs and LCLs treated with relaBoNT-A in the RELAX and EXPRESSION trials. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Nikolis A, et al. Preferences and experiences across biostimulatory poly-L-lactic acid’s reconstitution processes and injection criteria (PREP study). Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Shridharani SM, et al. Efficacy and safety of RelabotulinumtoxinA, a new ready-to-use liquid formulation botulinum toxin: Results from the READY-1 double-blind, randomized, placebo-controlled phase 3 trial in glabellar lines. Aesthet Surg J. 2024;44(12):1330-1340. doi: 10.1093/asj/sjae131.

    Ascher B, et al. Consensus Recommendations on the Aesthetic Use of RelabotulinumtoxinA to Treat Upper Face Wrinkles. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Fabi SG, et al. The potential role of biostimulators/dermal fillers to address menopause-related skin conditions. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

    Galderma. Data on file. Menopause Patient Survey.

    Waibel J, et al. Bulk RNA-seq Analysis of Poly-L-Lactic Acid (PLLA-SCA) vs Calcium Hydroxyapatite (CaHA-R) Reveals a Novel, Adipocyte Mediated Regenerative Mechanism of Action Unique to PLLA. Poster presented at ASDS 2024 Annual Meeting; October 17-20, 2024; Orlando, Florida, United States.

    Waibel J, et al. Gene Analysis of Biostimulators: PLLA-SCA Triggers Regenerative Morphogenesis while CaHA-R Induces Inflammation upon Facial Injection. Poster presented at ASDS 2024 Annual Meeting; October 17-20, 2024; Orlando, Florida, United States.

    Huth S, et al. Molecular Insights into the effects of PLLA_SCA on Gene Expression and Collagen Synthesis in Human 3D Skin Models Containing Macrophages. J Drugs Dermatol. 2024;23(4):285–288. doi: 10.36849/JDD.7791.

    Galderma. Data on File. MA-46589.

    Vleggaar D, et al. Consensus recommendations on the use of injectable poly-L-lactic-acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(4 Suppl):s44–s51.

    Widgegrow J, et al. A randomized, comparative study describing the gene signatures of poly-l-lactic acid (PLLA-SCA) and Calcium Hydroxyapatite (CaHA) in the treatment of nasolabial folds. Poster presented at IMCAS World Congress; February 1-3, 2024. Paris, France.

    Duracinsky M, et al. Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients. BMC Infect Dis. 2014;14(474). doi: 10.1186/1471-2334-14-474.

    Zhang S and Duan E. Fighting against Skin Aging: The Way from Bench to Bedside. Cell Transplant. 2018;27(5):729–738. doi: 10.1177/0963689717725755.

    Shuster S, et al. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93(6):639-43. doi: 10.1111/j.1365-2133.1975.tb05113.x.

    Zarbafian M, et al. The emerging field of regenerative aesthetics—where we are now. Dermatol Surg. 2022;48:101–108. doi: 10.1097/DSS.0000000000003239.

    Fabi S, et al. 24-month clinical trial data on effectiveness and safety after correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant. Poster presented at IMCAS World Congress; January 26-28, 2023; Paris, France.

    Goldberg D, et al. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915–922. doi: 10.1111/dsu.12164.

    Di Gregorio C, et al. 25+ years of experience with the Restylane portfolio of injectable HA fillers for facial aesthetic treatment. E-poster presented at AMWC; March 27-29, 2024; Monaco.

    Nikolis A, et al. The role of clinical examination in midface volume correction using hyaluronic acid fillers: should patients be stratified by skin thickness? Aesthet Surg J Open Forum. 2020;2(1):1–12. doi: 10.1093/asjof/ojaa005.

    Talarico S, et al. High patient satisfaction of a HA filler producing enduring full-facial volume restoration: an 18- month open multicenter study. Dermatol Surg. 2015;41:1361–1369. doi: 10.1097/DSS.0000000000000549.

    Restylane. U.S. Instructions for use. Available online. Accessed January 2026.

    Edsman K, et al. Gel properties of hyaluronic acid dermal fillers. Dermatol Surg. 2012;38:1170–1179. doi: 10.1111/j.1524-4725.2012.02472.x.

    Galderma. Data on file. MA-58650. Degree of modification of HA fillers.

    Seo K. Facial volumization with fillers. Springer. 2021;29–83. https://doi.org/10.1007/978-981-33-6212-3_2.

    Kablik J, et al. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009:35S(1):302–312. doi: 10.1111/j.1524-4725.2008.01046.x.

    Galderma Data on file. MA-56724. X-strain and G’ including Shaype.

    Nikolis A, et al. Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion. J Drugs Dermatol. 2024;23(4):255–261. doi: 10.36849/JDD.8145.

    Öhrlund Å et al. Differentiation of NASHA and OBT Hyaluronic Acid Gels According to Strength, Flexibility, and Associated Clinical Significance J Drugs Dermatol. 2024;23(1):1332–1336. doi: 10.36849/JDD.7648.

    Belmontesi M et al. Injectable Non-Animal Stabilized Hyaluronic Acid as a Skin Quality Booster: An Expert Panel Consensus J Drugs Dermatol. 2018;17(1):83–88.

    Solish N, et al. Dynamics of HA fillers formulated to maintain natural facial expression. J Cosmet Dermatol. 2019;18(3):738-746. doi: 10.1111/jocd.12961.

    Philipp‐Dormston WG, et al. Perceived naturalness of facial expression after HA filler injection in nasolabial folds and lower face. J Cosmet Dermatol. 2020;19(7):1600-1606. doi: 10.1111/jocd.13205.

    Ablon G, et al. Treatment of lateral canthal lines with RelabotulinumtoxinA, an investigational liquid botulinum toxin: clinical efficacy and safety results from the READY-2 phase 3 trial. Toxicon. 2024;237(1):107353. doi: 10.1026/j.toxicon.2024.107353.

    Relfydess®. EU Summary of Product Characteristics.

    Sundberg AL and Stahl U. Relabotulinum toxin - a novel, high purity BoNT-A1 in liquid formulation. Presented at TOXINS; January 16-17, 2021; virtual meeting.

    Do M, et al. Purification process of a complex-free highly purified botulinum neurotoxin type A1 (BoNT-A1) - relabotulinumtoxinA. Presented at TOXINS; July 27-30, 2022; Louisiana, United States.

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260121547346/en/

Permalink
https://www.aetoswire.com/en/news/2201202652534

Contacts

For further information:

Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62

Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87

Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12

Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43

State Street and QNB Group Sign Strategic Agreement to Launch New Custody Servicing Model

 

Strengthening State Street’s Growth in Qatar and QNB’s International Presence

 

State Street Corporation (NYSE: STT) and QNB Group today at the World Economic Forum (WEF), announced a strategic alliance to introduce a new custody servicing model in Qatar. Under this co-operation agreement, State Street and QNB Group have agreed to collaborate, with service agreements to be finalized and executed at a later date.

In the presence of His Excellency Ali bin Ahmed Al Kuwari, Qatar’s Minister of Finance, the co‑operation agreement was signed during the WEF currently held in Davos, Switzerland, marking a significant milestone in State Street’s ongoing expansion within the Gulf Cooperation Council (GCC) and supporting QNB’s accelerating international growth.

This step reflects the strong market leadership of QNB Group, Qatar’s largest financial institution and a recognized leader in regional custody and asset‑servicing capabilities. The agreement will also strengthen QNB’s role as the country’s most trusted provider of local market access, regulatory expertise, and institutional‑grade safekeeping, as well as State Street’s market position in Qatar.

Bringing together State Street’s global scale and QNB’s deep local insight, this strategic alliance will enhance service delivery for clients and reinforce the two institutions’ combined presence in Qatar’s financial market.

“The GCC is one of the fastest-growing markets globally, and we are committed to deepening our presence through collaboration with leading local institutions”, said Ron O’Hanley, chairman and CEO at State Street. “This new servicing model creates significant synergies, enabling us to deliver enhanced solutions to clients across the region. QNB’s scale and network in Qatar are important to State Street as we invest further to support GCC clients in capturing opportunities driven by the region’s economic transformation.”

“This strategic alliance with State Street marks a pivotal moment for QNB Group and is fully aligned with our vision for sustained international expansion and market leadership,” said Abdulla Mubarak Al-Khalifa, Chief Executive Officer at QNB Group. “By leveraging State Street's world-class global custody and value-added services, we are significantly enhancing our operational capabilities and service offering. This collaboration is instrumental in further solidifying our position as a dominant financial institution both locally and across our expanding international footprint, allowing us to leverage State Street’s global expertise to expand our offerings and strengthen client relations, driving robust growth in key markets outside of Qatar. We are creating a superior servicing model that reflects our unwavering commitment to strategic partnerships, while maximizing stakeholder value on a global scale.”

With offices in Abu Dhabi, Dubai, Muscat and Riyadh, State Street has been servicing sovereign wealth funds, pension schemes, central banks, and asset managers in the Middle East for over three decades. State Street has a total of $12.92 trillion in asset under custody / administration and $841 billion of asset under management in EMEA.

QNB Group Custody received regulatory approval from the Qatar Financial Market Authority in 2012 to provide custody services both in Qatar and internationally, leveraging subsidiaries in Egypt and Turkey and an extensive global network of sub-custodians. With $65 billion in assets under custody, QNB Custody serves a diverse client base, including global custodians, financial institutions, asset managers, and government entities.

About State Street Corporation

State Street Corporation (NYSE: STT) is one of the world's leading providers of financial services to institutional investors including investment servicing, investment management and investment research and trading. With $53.8 trillion in assets under custody and/or administration and $5.7 trillion* in assets under management as of December 31, 2025, State Street operates globally in more than 100 geographic markets and employs approximately 52,000 worldwide. For more information, visit State Street's website at www.statestreet.com.

*Assets under management as of December 31, 2025 includes approximately $173 billion of assets with respect to SPDR® products for which State Street Global Advisors Funds Distributors, LLC (SSGA FD) acts solely as the marketing agent. SSGA FD and State Street Investment Management are affiliated.

About QNB Group

QNB Group is one of the leading financial institutions in the Middle East and Africa and is ranked as the most valuable banking brand in the MEA region. Present in over 28 countries across Asia, Europe, and Africa, it offers tailored products and services supported by innovation and backed by a team of over 31,000 professionals dedicated to driving banking excellence, worldwide.

© 2026 State Street Corporation

 

Permalink
https://aetoswire.com/en/news/qnbss22012026e

Contacts

For media inquiries, please contact: Khalil BouDargham KBouDargham@webershandwick.com

World Governments Summit 2026 to Include Largest International Participation Yet

 WGS 2026 Hosts High Level Investment Forum Latin America & Caribbean, and World Laureates Summit's Global First

 

The 2026 edition of the World Governments Summit (WGS) will host the largest ever international participation since its inception and convene several landmark forums, underlining its rising global stature and significance.

The roster of world-leading corporations and knowledge institutions at the global forum includes the International Monetary Fund (IMF), International Finance Corporation (IFC), a member of The World Bank, as well as more than 35 heads of state, government delegations, and 150+ governments.

WGS 2026 also hosts multiple world-class forums, notably the New Silk Road Forum, the high-level IFC-led Investment Forum - Latin America & the Caribbean, 10th International Cooperation Conference in collaboration with the Association of Caribbean States, and the Future of Economy Forum.

Also marking its global debut outside Shanghai, China is the World Laureates Summit (WLS), which brings together winners of the Nobel Prize, Turing Award, Fields Medal, Great Arab Minds, and major international scientific honorees. Taking place on 3-5 February,  the largest event of its kind to be hosted in collaboration with the World Laureates Association, will bring together laureates and world leaders to shape science-led solutions targeting pressing global challenges.

Notable attendees confirmed to attend include Michael Levitt (2013 Nobel in Chemistry), Kip Thorne (2017 Nobel in Physics), and John Hopcroft (1986 Turing Award).

The outcomes of the World Laureates Summit will be announced during WGS 2026.

The World Governments Summit 2026 will be held from 3-5 February under the theme ‘Shaping Future Governments’, with the largest international participation in the Summit’s history.

Comprising more than 320 sessions, the Summit will host over 100 international and regional organisations and 450+ global figures, including presidents, ministers, experts, thought leaders and decision-makers.

The World Governments Summit 2026 agenda features 24 specialised global forums dedicated to anticipating future trends across vital sectors.

 

Permalink

https://www.aetoswire.com/en/news/wgs2212026e

Contacts

Ahmed Yahya

ayahya@apcoworldwide.com

UAE Research Program for Rain Enhancement Science Announces Awardees of 6th Cycle Grants

 Abu Dhabi, United Arab Emirates - Wednesday, 21. January 2026 AETOSWire Print 

The UAE Research Program for Rain Enhancement Science (UAEREP), managed by the National Center of Meteorology (NCM), announced the awardees of its Sixth Cycle research grants. Each recipient will receive up to US$1.5 million over three years, with a maximum annual allocation of US$550,000.

The Sixth Cycle awardees are Dr. Dixon Michael, Principal Radar Meteorologist and Software Engineer at Echo Science Works, USA, for “Advancing Cloud Seeding Science with Dual-Polarization Radar Signatures and AI”; Prof. Linda Zou, Adjunct Professor at Victoria University, Australia, for “AI-assisted Development and Optimization of Glaciogenic Cloud Seeding Materials”; and Dr. Oliver Branch, Senior Scientist at the University of Hohenheim, Germany, for “Rainfall Enhancement through Modification of Land Cover and Land Form (RAINLAND).”

His Excellency Dr. Abdulla Al Mandous, President of the World Meteorological Organization and Director General of NCM, said: “Under the guidance of His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister, and Chairman of the Presidential Court, UAEREP continues to strengthen its position as a global platform for scientific collaboration and applied innovation. NCM plays a central role in enabling this work through advanced infrastructure and operational expertise that translate research into real-world impact. This reflects the UAE’s approach of investing in practical and sustainable innovation.”

Alya Al Mazrouei, Director of UAEREP and Director of the Research and Weather Enhancement Department at NCM, said: “The awardees’ proposals demonstrate high standards of scientific innovation and practical application. Through UAEREP’s technical resources and global collaborations, these projects will deliver science-based solutions that contribute to water security and climate resilience.”

Dr. Dixon Michael’s project advances the evaluation of cloud seeding impacts beyond traditional reflectivity-based storm tracking. It will upgrade LROSE/TITAN to capture microphysical pathways and assess impacts using transparent, uncertainty-aware methods, while strengthening NCM’s capacity to sustain these systems.

Prof. Linda Zou’s project will develop advanced nanocomposite ice-nucleating materials and apply AI-driven analytics to optimize their performance using data from a Portable Ice Nucleation Experiment (PINE) cloud chamber, which will be deployed at NCM in the final phase of the project.

Dr. Oliver Branch’s RAINLAND project will apply a theory–observation–simulation approach to demonstrate how land-cover and land-topography modifications can trigger moist convection. The research aims to identify optimal land-form designs and locations to enhance rainfall in the UAE.

Permalink

https://www.aetoswire.com/en/news/2101202652492

Contacts

Salam Shehady

sshehady@apcoworldwide.com

WEF26: Saudi Arabia leads new global push to protect coral reefs, unlock AI potential

Davos, Switzerland - Thursday, 22. January 2026

The Saudi delegation to the World Economic Forum (WEF) Annual Meeting 2026 today observed a series of announcements aimed at addressing urgent global challenges.

Her Royal Highness Ambassador Reema Bandar Al-Saud, Ambassador of the Kingdom of Saudi Arabia to the United States of America, announced that Saudi Arabia will host the first Global Coral Reef Summit in 2026, bringing together global leaders, scientists, and investors to drive solutions for the protection and recovery of coral reef ecosystems.

The summit will address key challenges and policy and regulatory gaps, develop science-based solutions, and advance sustainable financing and investment mechanisms to scale coral reef protection and recovery.

Building on the call for constructive dialogue in an era of fragmentation, His Excellency Ahmed A. Alkhateeb, Minister of Tourism, said: “Tourism brings peace at a time when it’s needed – connecting people and encouraging dialogue. Tourism growth is good for peace, it’s good for people, good for youth, and good for women.”

On the Kingdom’s ambitions to become a global hub for AI, His Excellency Abdullah A. Alswaha, Minister of Communications and Information Technology, commented: “Saudi Vision 2030 was about economic diversification and empowering youth. Fast forward to today and we've achieved 56% non-oil contribution to GDP, and in terms of talent and youth, our tech force has increased dramatically.”

Earlier in the day, HUMAIN and the National Infrastructure Fund (“Infra”) announced a Strategic Financing Framework Agreement of up to $1.2 billion to support the expansion of AI and digital infrastructure projects in the Kingdom. The agreement outlines non-binding financing terms for HUMAIN’s development of up to 250 MW of hyperscale AI data center capacity.

The United Nations Convention to Combat Desertification (UNCCD) COP16 Presidency also launched the Business4Land (B4L) Champions’ Council. This high-level coalition brings together CEOs, sustainability leaders, investors, and policymakers to accelerate land restoration, combat land degradation, and strengthen drought resilience.

 

The Ministry of Industry and Mineral Resources (MIM,) in collaboration with WEF, announced the Lighthouse Operating System, a country-level framework designed to accelerate manufacturing transformation. Developed in partnership with WEF’s Advanced Manufacturing and Production Centre (AMPC), this initiative aims to diversify the Kingdom’s economy, build robust non-oil industries, and position Saudi Arabia as a global hub for advanced manufacturing and logistics.

 

MIM and WEF announced a cooperation agreement on the sidelines of the Future Minerals Forum, which took place the week before the WEF Annual Meeting. The agreement runs until September 2027 and aims to unify efforts to strengthen partnerships around critical minerals required for energy and other technologies, contributing to the assurance of resilient, sustainable, and responsible mineral supplies aligned with industrial objectives and the energy transition. According to the agreement, the initiative will be overseen by a joint executive committee comprising representatives from the ministry and WEF.

Permalink

https://www.aetoswire.com/en/news/wef26:-saudi-arabia-leads-new-global-push-to-protect-coral-reefs,-unlock-ai-potential

Contacts

Danah Alhumaid

dalhumaid@mep.gov.sa

Bureau Veritas Named Accredited EcoVadis Consulting Partner

 

COURBEVOIE, France - 

(BUSINESS WIRE) -- Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), has been named as an Accredited Consulting Partner by EcoVadis, the global standard for resilient, sustainable supply chains. Accredited Consulting Partners are formally equipped to help businesses complete sustainability assessments, review scores, and improve Environment, Labor and Human Rights, Ethics, and Sustainable Procurement practices.

Accredited Consulting Partners are carefully selected based on their experience and expertise and must complete rigorous training on EcoVadis’ methodology and assessment process through the EcoVadis Academy. To qualify, partners must demonstrate a deep understanding of local environmental, ethical and human rights regulations and issues, and have completed the EcoVadis assessment for their own business.

“Becoming an EcoVadis Accredited Consulting Partner reinforces our commitment to enabling businesses to build resilient and responsible supply chains”, said Marc Roussel, Executive Vice President, Urbanization and Assurance at Bureau Veritas. “Bureau Veritas has a long-standing legacy of helping companies ensure integrity and resilience across global supply chains. Our partnership with EcoVadis further reinforces our commitment to guiding businesses toward sustainable transformation and help clients not only meet compliance requirements but also embed sustainability into their procurement strategies and operational frameworks."

As an Accredited Consulting Partner, Bureau Veritas offers end-to-end support for supply chain sustainability through:

Assessment Completion & Compliance Readiness – Guiding suppliers and buyers through EcoVadis assessments and sustainability reporting.

Post-Assessment Review & Strategic Integration – Translating scores into actionable improvement plans for long-term impact.

Program Launch & Network Engagement – Helping buyers implement sustainability programs across global supplier networks.

Advanced Value Chain Performance – Driving measurable improvements in responsible sourcing, traceability, and resilience.

Building on its expertise in guiding organizations through sustainability transitions, Bureau Veritas combines compliance, risk management, and transformation strategies to help businesses embed sustainability into their operations and supply chains. This approach includes diagnostics, advisory, performance monitoring, and certification, with a strong emphasis on responsible sourcing, social audits, traceability, and resilience – enabling companies to meet global standards, enhance transparency, and deliver measurable impact.

***

About Bureau Veritas:

Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress. With a vision to be the preferred partner for customers’ excellence and sustainability, the company innovates to help them navigate change.

Created in 1828, Bureau Veritas’ 84,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.

Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40, CAC 40 ESG, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.

For more information, visit http://www.bureauveritas.com, and follow us on LinkedIn.

Our information is certified with blockchain technology. Check that this press release is genuine at www.wiztrust.com.

About EcoVadis:

EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. In 2024, EcoVadis acquired Ulula, a leading worker voice platform that strengthens its capabilities in supporting human rights due diligence. With global, trusted and actionable ratings, businesses of all sizes rely on EcoVadis’ detailed insights to comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 250 industries in 185 countries. Leaders like Johnson & Johnson, L’Oréal, Unilever, Bridgestone, BASF and JPMorgan are among 150,000+ businesses that use EcoVadis ratings, risk, and carbon management tools and e-learning platform to accelerate their journey toward resilience, sustainable growth and positive impact worldwide.

Learn more on: ecovadis.com, X or LinkedIn.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260122971773/en/

Permalink

https://aetoswire.com/en/news/2201202652561

Contacts

ANALYST/INVESTOR

Laurent Brunelle

+33 (0)1 55 24 76 09

laurent.brunelle@bureauveritas.com

Colin Verbrugghe

+33 (0)1 55 24 77 80

colin.verbrugghe@bureauveritas.com

Romain Gorge

romain.gorge@bureauveritas.com

Inès Lagoutte

ines.lagoutte@bureauveritas.com

MEDIA

Frédéric Vallois

+33 (0)6 21 66 31 04

frederic.vallois@bureauveritas.com

MEDIA

US: Corporate Ink

617-969-9192, ecovadis@corporateink.com

FR: Agence Raoul

Alyssa Zayani - 06 59 09 00 56 - alyssa@agenceraoul.com

Chiara Serafini - 06 63 64 18 03 - chiara@agenceraoul.com

Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership

  ZUG, Switzerland - Thursday, 22. January 2026 AETOSWire  

(BUSINESS WIRE) -- Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the termination of a 2014 neuromodulator research & development partnership with Ipsen. The partnership was limited to the rights and obligations relating to the companies’ early-stage neuromodulator pipeline for aesthetic indications.

Galderma welcomes the clarity provided by the arbitral tribunal. This decision has no impact on the commercialization of Galderma’s neuromodulator portfolio. Galderma will continue to commercialize and supply Dysport®/Azzalure®, Alluzience®, and RelfydessTM in all territories where it has regulatory approval and in accordance with our existing agreements with our partner Ipsen.

Progressing on our path towards becoming the undisputed dermatology powerhouse

Galderma remains focused on its ambition to become the world’s undisputed dermatology powerhouse across the full spectrum of a fast-growing market, spanning Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Galderma’s business model is flexible – from in-house development to external partnerships.

In Injectable Aesthetics specifically, Galderma is on a strong trajectory to become the global leader, not just in sales and market share, but also in innovation. The company is well positioned to lead across the full value chain, with in-house capabilities spanning the discovery, research, development, manufacturing, and marketing of best-in-class products globally.

We have proven our capabilities with Restylane® – the broadest HA filler portfolio in the industry; Sculptra® – the first proven regenerative biostimulator; and more recently with RelfydessTM – the first and only ready-to-use liquid neuromodulator created with our proprietary PEARLTM Technology.

About Galderma

Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260121298885/en/

Permalink

https://www.aetoswire.com/en/news/2201202652503

Contacts

For further information:

Christian Marcoux, M.Sc.

Chief Communications Officer

christian.marcoux@galderma.com

+41 76 315 26 50

Richard Harbinson

Corporate Communications Director

richard.harbinson@galderma.com

+41 76 210 60 62

Emil Ivanov

Head of Strategy, Investor Relations, and ESG

emil.ivanov@galderma.com

+41 21 642 78 12

Jessica Cohen

Investor Relations and Strategy Director

jessica.cohen@galderma.com

+41 21 642 76 43

BitGo Holdings Celebrates its Debut as a Public Company on the New York Stock Exchange

 NEW YORK 

(BUSINESS WIRE) -- BitGo Holdings, Inc. (“BitGo”, the “Company”, “we”), the digital asset infrastructure company, today celebrates its debut on the New York Stock Exchange (“NYSE”) as a publicly traded company under the ticker symbol “BTGO”. Members of BitGo’s leadership team will be ringing the NYSE Opening Bell today at 9:30am ET.

“Today marks a defining moment for BitGo,” said Mike Belshe, CEO and Co-Founder of BitGo. “Our entry into the public markets will enable us to further accelerate the financial system’s transition toward a transparent and credible digital asset economy, while continuing to deliver exceptional security, custody and liquidity solutions for our clients. We believe that the opportunity ahead is significant and that we are uniquely positioned to help institutions navigate the road ahead.”

Belshe continued, “I am incredibly proud of the company we’ve built, and deeply grateful to our team for their hard work and dedication in reaching this milestone. As we take this next step into the public markets, we are looking forward to not only strengthening our own foundation, but also advancing the growth and resilience of the entire digital asset ecosystem.”

BitGo’s public debut follows more than a decade of growth and innovation, rooted in a continuous commitment to provide our clients with safe and secure digital asset solutions. We have evolved from a pioneer of multi-signature security and institutional-grade wallets to establishing the BitGo Bank & Trust, National Association, formerly known as BitGo Trust Company, Inc., and BitGo Prime Trading as well as launching our OTC trading desk and Stablecoin-as-a-Service and Crypto-as-as-Service solutions. We believe this growth has earned us a reputation of being a critical partner to digital asset ecosystems, financial institutions, technology platforms, corporations and governments.

We are a leader in the digital asset economy, serving more than 4,900 clients across over 100 countries and supporting more than 1,550 digital assets as of September 30, 2025. From our origins in safety and security, we provide secure and scalable solutions, offering self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service to investors, builders and other participants in the digital asset ecosystem.

Headquartered in Sioux Falls, BitGo has been a pioneer in digital asset security and regulatory compliance. As a newly listed company, BitGo is poised to leverage its trusted infrastructure and comprehensive product suite to shape the future of digital finance built on transparency, accountability, and trust.

This press release is neither an offer to sell nor a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

About BitGo

BitGo is the digital asset infrastructure company delivering custody, wallets, staking, trading, financing, stablecoins, and settlement services from regulated cold storage. Since 2013, BitGo has focused on accelerating the transition of the financial system to a digital asset economy. BitGo maintains a global presence and multiple regulated entities, including BitGo Bank & Trust, National Association, a federally chartered digital asset bank. Today, BitGo serves thousands of institutions, including many of the industry's top brands, financial institutions, exchanges, and platforms, and millions of investors worldwide.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include all statements that are not historical facts. These statements may include words such as “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “foreseeable,” “guidance,” “intend,” “likely,” “may,” “objectives,” “outlook,” “plan,” “potentially,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would,” or variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors include but are not limited to those described under “Risk Factors” in BitGo’s registration statement on Form S-1, as amended, relating to the initial public offering. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in the registration statement. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260121431073/en/

Permalink

https://www.aetoswire.com/en/news/2201202652572

Contacts

Investor Contact

investors@BitGo.com

Media Contact

press@BitGo.com

2026 Japan Prize Laureates Announced

 (BUSINESS WIRE)--The Japan Prize Foundation announced the winners of the 2026 Japan Prize at 1:00 p.m. (JST) on 21 January 2026. Prof. Cynthia Dwork (USA) has been awarded the Japan Prize in the field of Electronics, Information, and Communication. Prof. Shizuo Akira (Japan) and Prof. Zhijian "James" Chen (USA) have been awarded the Japan Prize in the field of Life Sciences.

For this year’s Japan Prize, Prof. Dwork is being recognized for her Contribution to leading research for building an ethical digital society, including differential privacy and fairness. Prof. Akira and Prof. Chen are being recognized for their Discovery of the nucleic acid sensing mechanism by the innate immune system.

For the 2026 Japan Prize, the Foundation asked approximately 16,000 prominent scientists and engineers from around the world to nominate researchers working in this year’s fields. We received 107 nominations for the field of Electronics, Information, and Communication, and 185 nominations for the field of Life Sciences. This year’s winners were selected from a total of 292 nominees.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260113214289/en/

Permalink

https://www.aetoswire.com/en/news/2101202652440

Contacts

Kiyoshi OGURA

Press Officer

The Japan Prize Foundation

Public Relations

Tel: 81-80-2003-1931 (81-3-5545-0551)

Fax: 81-3-5545-0554

E-Mail: ogura@japanprize.jp

 

Andersen Consulting Strengthens Digital Transformation Offering with Addition of Internet & Idee

 SAN FRANCISCO - 

(BUSINESS WIRE) -- Andersen Consulting enters into a Collaboration Agreement with Internet & Idee, an Italian-based digital consulting agency, enhancing its ability to deliver integrated, tech-driven solutions.

Founded in 1998, Internet & Idee delivers digital strategy, software development, Testing & QA, e-commerce, and mobile solutions. The firm operates across two core areas: IT consulting services and proprietary SaaS products, including credit management and cybersecurity monitoring tools. With deep expertise in banking, insurance, credit management, and luxury e-commerce logistics, Internet & Idee combines sector insight with technical innovation to drive business performance.

“This collaboration allows us to apply our digital and sector expertise at greater scale,” said Carlo Stumpo, CEO of Internet & Idee. “Together with Andersen Consulting, we can deliver more targeted, effective solutions for clients facing complex challenges in highly regulated and fast-moving industries.”

Mark L. Vorsatz, global chairman and CEO of Andersen, added, “Internet & Idee brings a unique blend of technical expertise and creative vision. Their capabilities strengthen our ability to help clients modernize how they engage with customers, operate with agility, and scale in a digital-first world. We are pleased to welcome them into our growing platform.”

Andersen Consulting is a global consulting practice providing a comprehensive suite of services spanning corporate strategy, business, technology, and AI transformation, as well as human capital solutions. Andersen Consulting integrates with the multidimensional service model of Andersen Global, delivering world-class consulting, tax, legal, valuation, global mobility, and advisory expertise on a global platform with more than 50,000 professionals worldwide and a presence in over 1,000 locations through its member firms and collaborating firms. Andersen Consulting Holdings LP is a limited partnership and provides consulting solutions through its member firms and collaborating firms around the world.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260121850878/en/

Permalink

https://www.aetoswire.com/en/news/2101202652489

Contacts

mediainquiries@Andersen.com

 

STREAMWIDE Marks Major APAC Milestone with UPCAD Public Safety Deployment in the Philippines

  MANILA, Philippines - Wednesday, 21. January 2026 AETOSWire Print 

(BUSINESS WIRE) -- STREAMWIDE has been selected by UPCAD (Unified Platform for Communication and Dispatch) of the Philippines to power its next generation critical communications platform for first responders integrated with national 911 call centers.

Through this collaboration, UPCAD integrates STREAMWIDE’s field proven mission critical technology with the national 911 services, the new solution is designed to ensure uninterrupted, secure, and reliable communication during emergencies, enabling faster response times, improved situational awareness, and enhanced public safety outcomes.

By integrating directly with 911 call centers, the platform enables real-time sharing of critical information such as caller location, incident details, and response status with first responders and command teams.

Through our API, the platform integrates digital workflow capabilities, allowing information to flow seamlessly into the same system. This enables up-to-date reporting while automatically creating incident workflows, assigning tasks, monitoring progress, and capturing real-time updates, capabilities unavailable in legacy LMR systems.

Unlike voice-only radio communications, this integrated approach gives dispatchers, responders, and supervisors a shared operational picture through incident history, automated reporting, standardized operating procedures, and real-time visibility. By combining digital workflows with voice and collaboration capabilities, the platform supports faster decision making, improved coordination, and accountability throughout the incident lifecycle.

The platform bridges the gap between emergency call intake and field operations, ensuring that no critical information is lost during high-pressure situations. Dispatchers and response teams can collaborate on a unified system that supports voice, data, and multimedia communication.

Key capabilities include:

Direct integration with 911 call center systems for real-time information sharing

Mission-critical voice and data communication with high availability and redundancy

Secure and encrypted channels to protect sensitive emergency data

Real-time location tracking and situational updates for faster decision-making

Scalable architecture to support city, regional, or national emergency networks

Pascal Beglin, CEO of STREAMWIDE, commented:

“Delivering trusted, mission critical technology at the highest level is central to our mission. Partnering with a leading public safety authority in the Philippines underscores the confidence placed in our capabilities and reflects the proven maturity of our solutions for first responders. We are particularly proud that our platform’s integration with national 911 services, combined with digital workflows and voice collaboration capabilities, will directly enhance operational efficiency, situational awareness, and coordination for first responders on the ground.

Being selected by UPCAD marks a major milestone for our APAC expansion and reinforces our ability to deliver secure, resilient, and innovative mission-critical services at scale.”

Rob Llaguno, Country Manager and Project Director for the National Unified 911 project, commented:

"It's an honor to be driving this revolutionary project that will unify communications across our Police, Fire, and 911 Emergency departments.

The application and use cases are numerous: bridging comms during disaster and calamity response, managing national events, providing ground and incident commanders with mission-critical communication solution, multimedia collaboration tools, and next-generation capabilities significantly enhances frontliners' coordination and situational awareness. This next level of efficiency ensures better safety for both the public and our first responders."

About STREAMWIDE (Euronext Growth: ALSTW - FR0010528059)

STREAMWIDE is a recognized global leader in secure, mission-critical and business-critical communication solutions. Trusted by public safety agencies and enterprises worldwide, STREAMWIDE delivers innovative platforms that combine resilience, interoperability, and ease of use. Its solutions empower organizations in public safety, defense, energy, transportation, and industry to collaborate more efficiently, respond faster, and operate with maximum security in the most demanding environments.

For more information: http://www.streamwide.com

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260120259542/en/

Permalink

https://www.aetoswire.com/en/news/2101202652455

Contacts

Media

Lobna Hermi

Corporate Communications

Phone: +33 1 70 22 01 01

lhermi@streamwide.com

Lindy Wong

General Manager APAC

Phone: +65 89288695

lwong@streamwide.com

FEM26 : « Le capital humain est le moteur clé de la compétitivité économique »

 

Davos, Suisse. 21 janvier 2026 – Pour que les économies restent compétitives à l’avenir, elles doivent donner la priorité à l’investissement dans le capital humain, a déclaré Son Altesse Royale la Princesse Reema Bandar Al-Saud, Ambassadrice du Royaume d’Arabie saoudite auprès des États-Unis d’Amérique, lors de la réunion annuelle 2026 du Forum économique mondial (FEM).

 

S’exprimant lors d’un panel au Pavillon de l’Arabie Saoudite (“Saudi House”), Son Altesse Royale a souligné: «Le capital humain est aujourd’hui le moteur clé pour qui souhaite une économie moderne et compétitive.»

 

Elle a ajouté: «Si vous donnez aux personnes les moyens d’agir et l’espace pour diriger, elles sauront s’en saisir et réussir. Et lorsque vous placez les bonnes personnes au bon endroit, au bon moment, la magie opère. Le Royaume est ce lieu, nous avons les talents, et le moment est venu.»

 

Son Excellence Ahmed A. Alkhateeb, ministre du Tourisme, a déclaré: «Nous nous étions fixé pour 2030 l’objectif d’accueillir 100 millions de touristes par an. Nous avons atteint ce cap avec sept ans d’avance, et depuis 2023, nous continuons à le dépasser chaque année, avec une croissance soutenue des dépenses touristiques d’année en année.»

 

Son Excellence Khalid A. Alfalih, ministre de l’Investissement, a commenté: «Nos investissements directs étrangers sont cinq fois supérieurs à leur niveau d’avant la Vision 2030 ; nos investisseurs locaux s’engagent avec leurs propres capitaux, l’investissement local a doublé, et nous avons atteint le niveau de la Chine et de l’Inde en matière de formation de capital en pourcentage du PIB.»

 

Son Excellence Mohammed A. Aljadaan, ministre des Finances, a expliqué comment la Vision 2030 a servi de feuille de route à une transformation nationale crédible: «La véritable réforme ne se mesure pas à la rapidité ou aux succès précoces, mais à sa pérennité – à sa capacité à transformer durablement le comportement des institutions et des marchés.»

 

Son Excellence Bandar I. Alkhorayef, ministre de l’Industrie et des Ressources minérales, a souligné que la jeunesse est une ressource rare dans les économies développées, ajoutant que le Royaume d’Arabie saoudite est « béni par sa jeunesse».

 

Son Excellence Faisal F. Alibrahim, ministre de l’Économie et de la Planification, a déclaré: «Pour avancer vers plus de résilience et de durabilité, le secteur privé joue un rôle plus  important , un rôle de co-leader ; l’innovation et la R&D occupent une place plus importante dans notre activité économique, et nous nous connectons et nous intégrons aux marchés mondiaux.»

 

Le ministère de l'Économie et de la Planification a annoncé qu'il lancera la plateforme SUSTAIN en version bêta en 2026 lors d'une conférence NextOn au Pavillon de l’Arabie Saoudite (“Saudi House”). SUSTAIN est un réseau de partenariat de mise en relation activé par l’IA, conçu pour renforcer la collaboration intersectorielle et accélérer la mise en œuvre des initiatives de développement durable. La plateforme a été développée en collaboration avec le FEM (Forum Économique Mondial) et Bain & Company.

 

Le Quality of Life Program Center et ONU-Habitat ont conjointement annoncé les résultats de l’Initiative Quality of Life, une plateforme mondiale qui soutient une approche du développement urbain centrée sur les personnes.  

 

SDM a annoncé un partenariat avec Weill Cornell Medicine – Cornell University, intitulé «Frontier Science for Human Health: une collaboration de recherche spatiale entre l’Arabie saoudite et les États-Unis». Cet accord vise à faire progresser les technologies innovantes en biologie spatiale et computationnelle, en mettant l’accent  sur la recherche spatiale et les missions dédiées à la santé humaine.

---

Source: AETOSWire

 

Contact presse :
Danah Alhumaid
dalhumaid@mep.gov.sa